Literature DB >> 9735242

Sustained nitric oxide exposure decreases soluble guanylate cyclase mRNA and enzyme activity in pulmonary artery smooth muscle.

W S Scott1, D K Nakayama.   

Abstract

BACKGROUND: The soluble isoform of guanylate cyclase (sGC) is activated by nitric oxide (NO) to form guanoside 3':5'-cyclic monophosphate (cGMP). Cyclic GMP levels cause smooth muscle relaxation and regulate vascular tone to various vascular beds, including the lung. Under conditions of cytokine excess the inducible synthesis of NO may result in cGMP overproduction, generalized vasodilatation, and septic shock. In the pulmonary bed the opposite response, pulmonary hypertension, may occur. We hypothesized that sGC activity decreases in the face of sustained levels of NO.
MATERIALS AND METHODS: We used the NO-donor S-nitroso-acetyl-D-L-penicillamine to study the effects of NO on sGC mRNA abundance and enzyme activity in cultured rat pulmonary artery smooth muscle cells.
RESULTS: NO caused a prompt rise in extracellular cGMP production. Pretreating cells with NO for >/=45 min inhibited subsequent cGMP synthesis. NO-pretreated cells recovered the capacity for cGMP synthesis after removal of NO for 120 min. When actinomycin or cycloheximide was added to NO pretreatment, cells retained cGMP synthetic capacity. NO pretreatment decreased sGC mRNA abundance, but did not totally eliminate it.
CONCLUSION: NO has important regulatory effects on cGMP synthesis at the level of enzyme activity and mRNA abundance. NO causes an immediate synthesis of large amounts of cGMP. With prolongation of exposure (>/=60 min) sGC enzyme activity decreases and cGMP production drops significantly. Soluble GC mRNA abundance also decreases and may result in decreased responsiveness of cells to NO with regard to cGMP production. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9735242     DOI: 10.1006/jsre.1998.5382

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  10 in total

Review 1.  Soluble guanylate cyclases in the retina.

Authors:  Ari Sitaramayya
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 2.  The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.

Authors:  Tomas C Bellamy; John Garthwaite
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 3.  RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase.

Authors:  Iraida G Sharina; Gilbert J Cote; Emil Martin; Marie-Francoise Doursout; Ferid Murad
Journal:  Nitric Oxide       Date:  2011-08-16       Impact factor: 4.427

4.  Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.

Authors:  M B Hussain; A J Hobbs; R J MacAllister
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

5.  Downregulation of vascular soluble guanylate cyclase induced by high salt intake in spontaneously hypertensive rats.

Authors:  S Kagota; A Tamashiro; Y Yamaguchi; R Sugiura; T Kuno; K Nakamura; M Kunitomo
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

6.  Precapillary sphincters and pericytes at first-order capillaries as key regulators for brain capillary perfusion.

Authors:  Stefan Andreas Zambach; Changsi Cai; Hans Christian Cederberg Helms; Bjørn Olav Hald; Yiqiu Dong; Jonas Christoffer Fordsmann; Reena Murmu Nielsen; Jingshi Hu; Micael Lønstrup; Birger Brodin; Martin Johannes Lauritzen
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-29       Impact factor: 11.205

7.  The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats.

Authors:  Philipp Schwabl; Ksenia Brusilovskaya; Paul Supper; David Bauer; Philipp Königshofer; Florian Riedl; Hubert Hayden; Claudia Daniela Fuchs; Judith Stift; Georg Oberhuber; Stefan Aschauer; Diana Bonderman; Thorsten Gnad; Alexander Pfeifer; Frank Erhard Uschner; Jonel Trebicka; Nataliya Rohr-Udilova; Bruno Karl Podesser; Markus Peck-Radosavljevic; Michael Trauner; Thomas Reiberger
Journal:  Sci Rep       Date:  2018-06-19       Impact factor: 4.379

Review 8.  Emerging antenatal therapies for congenital diaphragmatic hernia-induced pulmonary hypertension in preclinical models.

Authors:  Kathleen Marulanda; Nick D Tsihlis; Sean E McLean; Melina R Kibbe
Journal:  Pediatr Res       Date:  2020-10-10       Impact factor: 3.756

9.  Mechanisms of activity-dependent plasticity in cellular nitric oxide-cGMP signaling.

Authors:  Edward J Halvey; Jeffrey Vernon; Brijesh Roy; John Garthwaite
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

10.  Characterization of the human alpha1 beta1 soluble guanylyl cyclase promoter: key role for NF-kappaB(p50) and CCAAT-binding factors in regulating expression of the nitric oxide receptor.

Authors:  Martín L Marro; Concepción Peiró; Catherine M Panayiotou; Reshma S Baliga; Sabine Meurer; Harald H H W Schmidt; Adrian J Hobbs
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.